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Abstract
Background: Adipose microenvironment is involved in signaling pathways that influence breast cancer. We aim to
characterize factors that are modified: 1) in tumor and non tumor human breast epithelial cell lines when incubated
with conditioned media (CMs) from human breast cancer adipose tissue explants (hATT) or normal breast adipose
tissue explants (hATN); 2) in hATN-CMs vs hATT-CMs; 3) in the tumor associated adipocytes vs. non tumor
associated adipocytes.
Methods: We used hATN or hATT- CMs on tumor and non-tumor breast cancer cell lines. We evaluated changes in
versican, CD44, ADAMTS1 and Adipo R1 expression on cell lines or in the different CMs. In addition we evaluated changes
in the morphology and expression of these factors in slices of the different adipose tissues. The statistical significance
between different experimental conditions was evaluated by one-way ANOVA. Tukey’s post-hoc tests were performed
within each individual treatment.
Results: hATT-CMs increase versican, CD44, ADAMTS1 and Adipo R1 expression in breast cancer epithelial cells.
Furthermore, hATT-CMs present higher levels of versican expression compared to hATN-CMs. In addition, we observed a
loss of effect in cellular migration when we pre-incubated hATT-CMs with chondroitinase ABC, which cleaves GAGs chains
bound to the versican core protein, thus losing the ability to bind to CD44. Adipocytes associated with the invasive front
are reduced in size compared to adipocytes that are farther away. Also, hATT adipocytes express significantly higher
amounts of versican, CD44 and Adipo R1, and significantly lower amounts of adiponectin and perilipin, unlike hATN
adipocytes.
Conclusions: We conclude that hATT secrete a different set of proteins compared to hATN. Furthermore, versican, a
proteoglycan that is overexpressed in hATT-CMs compared to hATN-CMs, might be involved in the tumorogenic behavior
observed in both cell lines employed. In addition, we may conclude that adipocytes from the tumor microenvironment
show a less differentiated state than adipocytes from normal microenvironment. This would indicate a loss of normal
functions in mature adipocytes (such as energy storage), in support of others that might favor tumor growth.
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Background
In addition to epigenetic and genetic changes that occur
within epithelial cells, research in the last few years has
shown that tumor progression also depends on the
dialog between tumor epithelial cells and surrounding
stromal cells [1]. Among the different cell types that sur-
round breast tumor epithelial cells, the most abundant
are those that compose breast adipose tissue, mainly
mature adipocytes, preadipocytes and adipose tissue
derived stem cells (ASC). Adipose tissue is a bioactive
endocrine organ [2, 3] that secretes soluble factors and
contributes significantly to the composition of the extra-
cellular matrix (ECM). Visceral adipose tissue is different
from peripheral adipose tissue since it produces a set of
unique cytokines and growth factors [4].
The importance of stromal adipocytes during the de-
velopment of the normal mammary gland has been re-
cently demonstrated [5]. In addition, in the past few
years several groups have demonstrated the importance
of the interaction that is established between tumor cells
and stromal adipocytes within the invasive front [6, 7].
Cells seem to be able to modify adipocyte phenotype,
which in turn, would stimulate tumor aggressive behav-
ior and local invasion [8]. The involvement of factors
such as leptin, adiponectin, COLVI, IL-6, HGF and
VEGF has been suggested, although there is still a lack
of results in human tissues that might confirm their role
as well as the potential involvement of new components.
Recent studies have demonstrated that growth factors
and cytokines secreted by adipose tissue have a signifi-
cant impact on the progression of several diseases, in-
cluding breast cancer [3, 8–12]. Statistics show that
breast cancer has one of the highest mortality rates
around the world. For women in Argentina it is the pri-
mary cause of death by cancer (20.1/100,000 women,
National Cancer Institute, Argentina, January 2016).
Therefore, from a clinical point of view, it is highly rele-
vant to study the involvement of breast adipose tissue in
breast cancer development. In particular, it would be
relevant to characterize factors secreted by these adipose
cells that could modify several aspects of normal and
tumor breast epithelial cell lines.
In this study, we focused on ECM proteins, adipokines
and their receptors. Versican, a chondroitin sulphate
proteoglycan is involved in intracellular signaling and in
connecting the cell with the ECM. Increased levels of
this proteoglycan have been found in some tumors [13, 14],
suggesting that an increase in versican might contribute to
tumor progression. Several works have shown that versican
seems to be involved in diverse cell functions such as adhe-
sion, migration and proliferation [15].
CD44, which is a transmembrane glycoprotein that
belongs to the family of cell adhesion molecules
(CAMs), regulates cell-cell and cell-matrix interactions.
Therefore, it plays a key role in cell adhesion and migra-
tion. It is also a marker for stem cells in several cell
types including epithelial cells and adipocytes [16, 17].
Some works have associated increased levels of CD44
with poor prognosis in cancer development [18, 19].
During the phase of tumor progression, degradation of
different local components of the ECM, followed by de novo
production of matrix proteins, seem to be fundamental
prerequisites for metastatic development. ADAMTS (a
disintegrin and metalloproteinase with thrombospondin
motifs) in particular are a group of proteases capable of
proteoglycan cleavage and ECM degradation. Some works
have described the differential expression of ADAMTS in
breast cancer, observing a deregulation of ADAMTS [20].
Adiponectin and leptin are the two main adipokines se-
creted by adipocytes. Their role on breast cancer has been
extensively studied. Most research show that leptin and
adiponectin have opposite effects on cancer development,
being leptin pro-tumorigenic and pro-angiogenic [21–23].
However results about these adipokines and their recep-
tors (Adipo R1, Adipo R2 and ObR) have sometimes been
contradictory and thus not conclusive [24].
Models used to study the dialogue between adipose
tissue and breast cancer include preadipocyte immortal-
ized cell lines, animal models and 3D culture systems.
We have recently shown that conditioned media (CMs)
from human breast cancer adipose tissue explants
(hATT) regulate proliferation, adhesion and migration of
breast cancer epithelial cell lines, as opposed to CMs
from normal breast adipose tissue explants (hATN) [12].
In the present work we aim to characterize factors that
are modified in tumor and non tumor human breast
epithelial cell lines when incubated with hATT- or
hATN-CMs, and are possibly involved in the regulation
of cell proliferation, adhesion and migration. Specifically,
we evaluated changes in the expression of versican,
CD44, ADAMTS1, and Adipo R1. In addition, we evalu-
ated the levels of versican and ADAMTS1 in hATN-
CMs vs their expression in hATT-CMs. Previously, we
have shown that hATT-CMs increase cell migration. In
the present work, we found that this effect is lost
when hATT-CMs are pre-treated with Chondroitinase
ABC. Finally, we observed changes in the phenotype
of the tumor associated adipocytes compared to non
tumor associated adipocytes; and evaluated by means
of immunohistochemistry the expression of versican,
adiponectin, AdipoR1, CD44 and perilipin (a marker
for mature differentiated adipocytes) [25] in hATT
and hATN.
The identification of these factors, both in adipose
tissue and epithelial cells, and the study of their possible
involvement in the regulation of tumor progression,
might help develop new strategies to prevent and/or
treat breast cancer.
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Methods
Reagents
Reagents were purchased from Sigma Chemical Co (St.
Louis, MO, USA), tissue culture flasks, dishes, and
multi-well plates were from Falcon Orange Scientific
(Graignette Business Park, Belgium), culture media and
supplements for both tissue and cell lines were from
Gibco BRL (Carlsbad, CA, USA).
Sample collection and handling
For the experiments we used fragments of adipose tissue
from both tumoral (hATT, n = 22) and normal breasts
(hATN, n = 16). These fragments were embedded in
paraffin. hATT tissue samples were obtained from estro-
gen and/or progesterone receptor positive, stage GH2,
infiltrating ductal carcinomas. None of the patients had
received chemotherapy or radiotherapy treatment.
hATN tissue samples were obtained from plastic surger-
ies performed for aesthetic reasons (breast reduction).
Al samples were processed within 2 h under a sterile
laminar flow hood. At arrival, tissue was transferred to a
Petri dish and was extensively washed with 50 ml ice
PBS supplemented with gentamicin (50 μg/ml). There-
after, tissues were transferred to a 50 ml centrifuge tube
containing 45 ml phosphate buffer saline solution (PBS)
at 37 °C and gently shaken for 5 min and centrifuged for
1 min at 277 x g at RT to remove red blood cells and
debris. Tissue was then removed from the tube and
weighed. hATT or hATN tissue was placed in a culture
flask with M199 culture medium (Invitrogen™) (1 g
tissue/10 ml M199) supplemented with gentamicin
(50 μg/ml) and incubated for 1 h at 37 °C in 5% CO2.
After this time, medium was removed and replaced with
fresh medium. After 24 h CM was collected, centrifuged,
filtrated and aliquoted into 1 ml fractions and immediately
stored at -80C, until its use. M199 medium was used as
Control-CM. All patients gave their written consent. Sam-
ples (tumor and normal) were collected following the
approval of the Ethics Committee of the IBYME [12].
Culture of tumor and non-tumor breast epithelial cell
lines
Immortalized epithelial cell lines from human tumor
(MCF-7 or IBH7) and non tumor (MCF10-A and
HBL100) breasts were used. MCF-7, MCF-10A and
HBL100 were obtained from the American Type Culture
Collection (ATCC, Rockville, MD, USA), whereas IBH-7
is a line immortalized from a primary breast tumor by
the laboratory of Dr. Isabel Luthy [26, 27]. MCF10-A cell
line cultures were grown in DMEM-F12 medium sup-
plemented with 10% bovine fetal serum (BFS), insulin
(2 μg/ml), cortisol (0.5 μg/ml) and EGF (20 ng/ml) and
antibiotics; while the remaining cell line cultures were
grown in DMEM-F12 supplemented with 10% BFS and
insulin (2 μg/ml), and antibiotics. All cultures were kept
at 37 °C in a 5% CO2 atm.
Breast epithelial cell proliferation assay
Tumor (3x103 MCF-7 or IBH-7 cells/well) and non-tumor
(5x103 MCF-10A or HBL100 cells/well) human breast epi-
thelial cell lines were incubated on 96-well plates with
complete DMEM-F12 for 24 h. Then, the four cell lines
were treated with hATN-, hATT- or control-CMs for an
additional 48 h, at 50% CM (50% hATN-, hATT- or
control-CMs and 50% DMEM-F12 medium) or 75% CM
(75% hATN-, hATT- or control-CMs and 25% DMEM-
F12 medium). The number of viable cells was determined
by a commercial colorimetric kit (Cell titer 96 AQueous
One Solution Cell Proliferation Assay, MTS). Results are
expressed as percentage of color intensity and normalized
to cells grown in control-CMs.
Preparation of cell lysates from breast epithelial cells
after incubation with hATN-CMs or hATT-CMs
MCF-10A, HBL100, MCF-7 and IBH-7 cells were seeded
in six-well plates in DMEM-F12 complete medium.
When cells reached 75–80% confluence, the medium
was aspirated and cells were washed twice with PBS.
Then, cells were incubated at 37 °C for 24 h either with
hATT-, hATN-, or control-CMs (50% CM, 50% DMEM-
F12). Cells were lysed with Ripa buffer, pelleted by
centrifugation at 4 °C and stored at −80 °C.
Immunofluorescence
Tumor (MCF-7 or IBH-7) and non-tumor (MCF-10A
and HBL100) were seeded on Lab Tek Chamber Slide
system until they reached 50–60% confluence. They
were then incubated with hATT-, hATN-, or control-
CMs for 24 h (50% CM, 50% DMEM-F12). An
additional control without primary antibody was per-
formed as antibody specificity control. Cells were fixed
with formaldehyde, washed, blocked and permeabilized
(PBS-BSA 0.2%-Triton X100 0.3% for 30 min). They
were then incubated with 100 μl of anti-versican primary
antibody (Santa Cruz, USA) at 4 °C. In order to increase
specificity, primary antibody unspecific activity was
blocked with goat serum. Cells were then washed and
incubated with the second antibody conjugated to FITC
(Sigma) for 1 h. Finally they were incubated for 10 min
with propidium iodide to visualize nuclei. Cell localization
(nuclear or cytoplasmic) was visualized, and fluorescence
intensity was quantified per cell using ImageJ 1.42q soft-
ware available at the NIH site (http://rsb.info.nih.gov/ij).
Western blot analysis
In order to evaluate protein expression levels, Western
blots were performed. Versican, CD44, ADAMTS1 and
Adipo R1 were measured after incubation of the
Fletcher et al. Journal of Experimental & Clinical Cancer Research  (2017) 36:26 Page 3 of 13
epithelial cell lines with the different CMs obtained. In
order to lyse cells, Ripa buffer was used (Tris 10 mM
pH 7,5; NaCl 150 mM; sodium vanadate 2 mM; sodium
deoxycholate; SDS 0,1%; igepal 1%; protease inhibitors).
In addition, versican and ADAMTS1 expression was
measured in CMs-hATT and CMs-hATN. Total protein
in samples was quantified by Bradford method. Proteins
were separated in a SDS-PAGE 10% gel, and electro-
transferred to a nitrocellulose membrane (Amersham).
The membrane was later blocked with bovine serum
albumin (Sigma-Aldrich, 0055 K) and then incubated
with the different antibodies ON at 4 °C. The mem-
branes were later washed, and incubated with proper
secondary antibodies conjugated to HRP. Antibody com-
plexes were visualized by means of chemiluminescence
(ECL; GE Helathcare). Band density was measured by
means of SCION ImageTM software (Scion Corporation,
Maryland, USA). In the cell extracts, β-actin level in
samples was used to determine that equal quantities of
proteins were loaded in the gel.. The assay for the CMs-
hATT and CMs-hATN was done by loading equal
volumes of each CM.
Breast epithelial cell migration assays (“wound-healing”)
The effect of hATN- or hATT-CMs, with or without
Chondroitinase ABC, on the motility of tumor breast epi-
thelial cell lines was evaluated by wound-healing assays.
MCF-7 and IBH-7 cells were grown on 96-well plates
with complete DMEM-F12 until cells reached 100%
confluence. After, cell monolayers were scratched with a
200 μl pipette tip, washed twice with PBS and hATN-,
hATT- or control-CMs were added. CMs were pre-
treated with Chondroitinase ABC (final concentration
80 mU/ml) (Sigma C2905) or PBS for 1 h at 37 °C. Im-
ages at time zero (0 h) were captured to record the ini-
tial width of the wounds, and the recovery of the
wounded monolayers due to cell migration toward the
denuded area was evaluated at 6 h. The images were
captured using an inverted phase-contrast microscope
(Olympus CKX-41; 4x objective). A quantitative analysis
of the wound closure was measured by Java Image J
(NIH, Bethesda, MD, USA) software using the freehand
selection mode and determined the relative wound clos-
ure respect to control of the wounded area after 6 h.
H&E staining
Tissues (hATT and hATN) were fixed in 4% formalde-
hyde and embedded in paraffin. They were afterwards
cut into sections of 3 μm thickness with a microtome,
deparaffinized and stained with hematoxylin-eosin
(H&E). Images were taken with a Nikon Eclipse E200
Microscope fitted with a digital still camera Micrometric
SE Premium (Nikon Corp., Japan) at 100x magnification.
Adipocyte area quantification (measuring adipocyte
perimeter) in the three tissue types was performed in 8–
10 fields of each preparation as mentioned above. In par-
ticular, we compared tissues obtained from hATN with
two different areas of hATT: adipose tissue attached to
the primary tumor; and adipose tissue obtained 2 cm
away from the tumor.
Immunohistochemistry
Serial cuts were performed on the same tissue samples
used for H&E staining. Versican, adiponectin, Adipo R1,
CD44, and perilipin expression were studied by means
of immunohistochemistry. Briefly, hATT and hATN
microtome slides were first deparaffinized, and then a
heat-mediated antigen retrieval, endogenous peroxidase
blocking and nonspecific tissue blocking were per-
formed. Slides were then incubated with the different
primary antibodies at 4 °C, and after that with an anti--
rabbit biotinylated secondary IgG antibody. Finally,
slides were incubated with peroxidase-conjugated strep-
tavidin. Peroxidase reaction was performed with chromo-
gen 3,3′-diaminobenzidine (DAB) (DAKO LSAB +Kit,
HRP). Hematoxylin counter stain was performed. Serial
cuts incubated in the absence of primary antibody were
used as negative controls. Images were taken with a Nikon
Eclipse E200 Microscope fitted with a Micrometric SE
Premium (Nikon Corp., Japan) digital still camera at 100x
and 400x magnifications. DAB staining quantification in
the three tissue types was performed in 8–10 fields of each
preparation as mentioned above.
Statistical analysis
The statistical significance between different experimental
conditions was evaluated by one-way ANOVA. Tukey’s
post-hoc tests were performed within each individual
treatment. The results are presented as mean ± SEM.
Results were considered significant at p < 0.05.
Results
hATT-CMs increase proliferation of tumor and non-tumor
epithelial cell lines in a dose-dependent manner
We evaluated the effect of human adipose tissue CMs
obtained from tumor (hATT) and normal (hATN)
breasts in the proliferation of MCF-10A, HBL100, MCF-
7 and IBH-7 cells. After 48 h of incubation, hATT-CMs
significantly increased proliferation of both tumor
(MCF-7 and IBH-7) and non-tumor (MCF-10A,
HBL100) epithelial cells, compared to the effect of
hATN-CMs and control -CMs (p < 0.001) (Fig. 1). In
addition, hATN-CMs did not modify the proliferation of
any of the four cell lines compared to control-CMs. A
significant increase of proliferation was observed when
tumor cell lines were incubated with 75% of the hATT-
CMs, compared to incubation with 50% of these same
CMs (p < 0.05) (Fig. 1).
Fletcher et al. Journal of Experimental & Clinical Cancer Research  (2017) 36:26 Page 4 of 13
These results are in accordance with previous ones by
our group [12], and suggest the presence of soluble fac-
tors in hATT-CMs (either absent or present at lower
concentrations, in hATN-CMs) that would stimulate the
proliferation of both tumor and non-tumor epithelial
cells. The characterization of soluble factors in both
CMs will help to elucidate this question.
hATT-CMs increase versican expression in breast cancer
epithelial cells
Versican proteoglycan can participate in the regulation
of cell motility, growth, differentiation and angiogenesis.
Its cell location has been described to depend on growth
conditions and cell type. Preliminary results had shown
presence of versican in the cell lines employed. Never-
theless, we modified the antibody protocol to confirm
the specificity of the antibody used to recognize versican
(primary antibody unspecific activity was blocked with
goat serum).
We found a nuclear and cytoplasmic localization of
versican in the four cell lines used, being more intense
in MCF-10A and HBL100 (Fig. 2a–d). In addition, we
observed a significant increase in total fluorescence in-
tensity in MCF-7 and IBH-7 cells incubated with
hATT-CMs compared to the expression found with
hATN-CMs and control-CMs (Fig. 2c and d). Further-
more, we found that when non-tumor cells, MCF10A
and HBL100, are treated with hATN-CMs, there is actu-
ally a decrease in fluorescence intensity for versican.
This decrease of intracellular versican could be due to
an increase of versican release to the ECM from both
non-tumoral cells or reduce expression of versican.
The increase in the expression of versican was also
observed by Western-blot, in cell lysates of MCF-7 and
IBH-7 incubated with hATT-CMs compared to the
expression found with hATN-CMs and control-
CMs (Fig. 2e).
hATT-CMs increase CD44, ADAMTS1 and Adipo R1
expression in breast tumor cancer epithelial cells
We evaluated possible changes in the expression of these
proteins in the different cell lines incubated with the
CMs (hATT-, hATN- or control-CMs).
We observed an increase in CD44 expression in tumor
cells MCF-7 and IBH-7 incubated with hATT-CMs
compared to the value observed with hATN- or control-
CMs (Fig. 3a).
ADAMTS1 is a member of a group of peptidases
(different from proteases) that are able to cleave proteo-
glycans and degrade the ECM. Our results indicate an
Fig. 1 Effect of CMs from hATN and hATT on proliferation of MCF-10A, HBL100, MCF-7 and IBH-7 cells. MCF-10A, HBL100, MCF-7 and IBH-7 cells were
incubated with hATN- (n = 10), hATT- (n = 12) or control-CMs 48 h, at 50% or 75% CM. Proliferation was measured by MTS assays. Data are shown
as the mean ± SEM (n = 5–7 experiments by triplicate). *p < 0.001 hATT-CMs vs. hATN-CMs or control-CMs (50% CMs); #p < 0.001 hATT-CMs vs.
hATN-CMs or control-CMs (75% CMs); **p < 0.05 50% hATT-CMs vs. 75% hATT-CMs
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Fig. 2 (See legend on next page.)
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increased expression of the 87 kDa form of ADAMTS1
in MCF-7 and IBH-7 tumor cells incubated with hATT-
CMs vs. hATN- or control-CMs (Fig. 3b).
Adipose tissue produces adiponectin, which has been
proposed to be involved in breast cancer regulation
through its membrane receptors. Our results indicate an
increased expression of Adipo R1 in MCF-7 and IBH-7
tumor cells incubated with hATT-CMs vs. hATN- or
control-CMs (Fig. 3b).
No significant differences were found with any treat-
ment in non-tumor cells MCF-10A and HBL100.
hATT-CMs present increased versican expression, and no
significant changes in ADAMTS1 expression, compared to
hATN-CMs
We evaluated the expression of the proteoglycan
versican and metalloproteinase ADAMTS1 in hATT-
and hATN-CMs. Previous research has described the
(See figure on previous page.)
Fig. 2 Effect of CMs from hATN and hATT in localization/expression of versican in MCF-10A, HBL100, MCF-7 and IBH-7 cells. a-d MCF-10A, HBL100,
MCF-7 and IBH-7 cells were seeded on Lab Tek Chamber Slide system and allowed to grow for 24 h. They were then incubated for 24 h with the
different CMs and versican immunodetection was performed. Fluorescence was observed with confocal microscopy. Representative images are
shown (scale bar: 20 μm). a MCF-10A, b HBL100, c MCF-7 and d IBH-7. Histograms show mean ± SEM of total cell fluorescence. Green: versican;
red: nuclei (a.u.: arbitrary units) (n = 3, duplicate experiments) *p < 0.001 hATT-CMs and/or hATN-CMs vs. control-CMs; **p < 0.01. hATT-CMs vs
hATN-CMs. e MCF-7 and IBH-7 were grown on 6 well plates, incubated for 24 h with the different CMs and cells were lysed. Versican expression
was measured by Western blot. 1- cells incubated with control-CMs; 2 and 3- cells incubated with hATN-CMs; 4 and 5- cells incubated with
hATT-CMs. β-actin was used as internal control. Images were analyzed by densitometry. Bars show mean± SEM of three independent experiments. *p<0.05
tumor cells incubated with hATT-CMs vs. hATN-CMs or control-CMs
Fig. 3 Effect of CMs from hATN and hATT on: CD44 (a); ADAMTS1 and Adipo R1 (b) expression was evaluated in MCF-7 and IBH-7 cells. MCF-7 and
IBH-7 cells were grown on 6 well plates, incubated for 24 h with the different CMs and then lysed. Expression of the different proteins was measured
by Western blot. 1- Cells incubated with control-CMs; 2 and 3- cells incubated with hATN-CMs; 4 and 5- cells incubated with hATT-CMs. β-actin was
used as internal control. Images were analyzed by densitometry. Histograms show mean ± SEM of three/five independent experiments. *p < 0.05 tumor
cells incubated with hATT-CMs vs. hATN-CMs or control-CMs
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differential expression of ADAMTS1 in breast cancer and
a deregulation of ADAMTS1 in this cancer type.
Our results indicate an increased expression of versi-
can in hATT-CMs compared to hATN-CMs. We found
that the 65kDA form of ADAMTS1 was present both in
hATT-CMs and hATN-CMs. Although no significant
differences were found in this protease, a tendency to be
augmented in the hATN-CMs was seen (Fig. 4). These
results indicate that adipose tissue present in tumor
breasts has increased versican secretion, compared to
adipose tissue from normal breasts.
Chondroitinase ABC treatment of hATT-CMs eliminates
their effect on cell migration of breast cancer epithelial
cells
We performed “wound healing” assays to evaluate the
effect on cell migration of MCF-7 and IBH-7 incubated
with control-, hATN- and hATT-CMs pre-treated (or
not) with chondroitinase ABC, an enzyme that degrades
versican’s GAG chains, therefore preventing effective
interaction between versican and tumor cells (via CD44).
CMs were pre-treated with Chondroitinase ABC (or
PBS) for 1 h at 37°c prior to the incubation of the cells.
We observed that in both cell lines hATT-CMs signifi-
cantly increased cell migration vs. control- and hATN-
CMs (Fig. 5a). Interestingly, this effect is lost when CMs
are pre-treated with chondroitinase ABC (Fig. 5b).
Adipocytes associated with the invasive front are reduced
in size compared to adipocytes that are farther away
We evaluated changes in the histoarchitecture of differ-
ent breast adipose tissues. In particular, we compared: 1)
adipose tissue from normal breasts; 2) adipose tissue
attached to the tumor; and 3) adipose tissue 2 cm away
from the tumor. We observed that the characteristics of
the connective tissue were modified as a response to
local invasion by tumor cells. Specifically, tumor associ-
ated adipocytes presented a reduced size compared to
adipose cells found farther away from the tumor’s
invasive front (Fig. 6).
hATT adipocytes showed significantly higher expression
of versican, Adipo R1 and CD44, and significantly lower
expression of adiponectin and perilipin, unlike hATN
adipocytes
We evaluated expression of versican, adiponectin,
Adipo R1, CD44, and perilipin expression of breast adi-
pose tissues. Compared to hATN, we found increased
expression of versican, Adipo R1 and CD44 both in
hATT attached to the tumor as well as in hATT 2 cm
from the tumor (Fig. 7a,c and d). In addition, hATT
attached to the tumor showed significantly increased
expression of Adipo R1 compared to hATT 2 cm from
the tumor (Fig. 7c). Conversely, hATT adipocytes
showed significantly lower expression of adiponectin and
a decrease in perilipin, unlike hATN adipocytes (Fig. 7b
and e). However, when we evaluated the levels of leptin
and of its receptor, ObR, we didn’t find a significant
difference between the samples tested (data not shown).
Discussion
Stromal-epithelial interactions mediate the development
and progression of breast cancer. Adipocytes are the
predominant stromal cell type in breast tissue. We have
recently shown that CMs from human adipose tissue
explants of breast tumors differentially regulate the pro-
liferation, adhesion and migration of breast cancer
epithelial cell lines, compared to CMs from adipose
tissue explants of normal breast samples [12]. In the
present work we aimed to characterize factors that could
be modified in tumor and non-tumor human breast
epithelial cell lines, when incubated with hATT- or
hATN-CMs, as possible candidate factors responsible of
the observed biological effects. Specifically, we evaluated
changes in the expression of versican, CD44, ADAMTS1
and Adipo R1. In addition, we evaluated the expression
of versican and ADAMTS1 in hATN-CMs vs their ex-
pression in hATT-CMs. Finally, we observed changes in
the phenotype of tumor-associated adipocytes compared
to non tumor associated adipocytes; and evaluated with
immunohistochemistry versican, adiponectin, Adipo R1,
Fig. 4 Versican and ADAMTS1 in hATT- and hATN-CMs. Versican and ADAMTS1 expression was evaluated by Western blot. Images were analyzed
by densitometry. Histograms show mean ± SEM of two independent experiments (n = 9). *p < 0.05 hATT-CMs vs. hATN-CMs
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CD44, and perilipin expression in hATT and hATN
slides. hATT-CMs significantly increased (in a dose
dependent manner) tumor and non tumor epithelial cell
proliferation. These results confirm previous observa-
tions already reported by our group, suggesting that
soluble factors present in hATT-CMs stimulate breast
epithelial cell proliferation in a dose-dependent manner,
whether cells are tumor or not. These factors would ap-
pear not to be present (or present at lower concentra-
tions) in hATN-CMs.
The identification of factors that might be modified in
tumor and non-tumor breast epithelial cell lines when in
contact with products secreted by adipose tissue from
breast cancer samples, could allow studying the
Fig. 5 Involvement of chondroitin sulfate proteoglycans on the effect of CMs from hATN and hATT on migration of MCF-7 and IBH-7 cells. Wound
healing assay (a,b). MCF-7 and IBH-7 cells were grown until they reached 100% confluence. After, cells were wounded and hATN-, hATT- or
control-CMs were added. CMs were pre-treated with Chondroitinase ABC (b) or PBS (a) for 1 h at 37 °C prior to the incubation of the cells. Images
were captured at the wound instant and after 6 h. Histograms show the closure after 6 h relative to the control and was plotted as mean ± SEM
of two/three independent experiments (n = 7 by duplicate). *p < 0.05 hATT-CMs vs. control-CMs; **p < 0.01 hATT-CMs vs. control-CMs; ***p < 0.001
hATT-CMs vs. hATN-CMs; ##p < 0.01 hATT-CMs vs. hATN-CMs
Fig. 6 Microscopic evaluation of different breast adipose tissues. Slides from: 1) adipose tissue samples from normal breasts of hATN; 2) adipose
tissue samples of tumor breast attached to the tumor of hATT; and 3) adipose tissue sample of tumor breast aproximately 2 cm away from the
tumor of hATT. Adipose tissue fragments were cut in paraffin, stained with H&E, and observed under light microscope. Adipocyte size was
quantified with Image J software (NIH). Histograms show mean ± SEM of two independent experiments. *p < 0.05 hATT attached to the tumor vs.
hATT 2 cm away from the tumor and hATN. Magnification: 100X
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mechanisms by which adipose tissue might regulate
tumor growth and progression. Previous works de-
scribed versican as a component of the ECM; and it has
been proposed that from this location it would help
regulate cellular mechanisms such as proliferation, mi-
gration and angiogenesis. Nevertheless, recent experi-
ments have also found an intracellular localization of
versican, which implies new action mechanisms for this
proteoglycan [28–30]. In accordance with these last re-
ports, we observed that versican presents both a nuclear
and a cytoplasmic distribution, although its nuclear
values were higher. In addition, when tumor cells were
incubated with hATT-CMs we observed an increase in
total cell fluorescence compared to hATN- and control-
CMs. Considering the nature of previous results, we
propose that the observed increase in fluorescence in-
tensity could be related to an increase in versican ex-
pression. We confirmed the observed increase of
expression with a Western blot. Since versican presents
4 different isoforms, and it has been already seen that
these isoforms have different functions [31], in future
works we will analyze if there are changes in the propor-
tion of these different isoforms, in addition to the
increase in total expression.
Fig. 7 Versican (a), Adiponectin (b), Adipo R1 (c), CD44 (d) and Perilipin (e) expression in the different adipose tissues. Versican, Adiponectin, Adipo R1,
CD44 and Perilipin expression was evaluated by immunohistochemistry in serial cuts belonging to the same three tissue samples mentioned in
Fig. 6. DAB staining quantification in the three tissue types was performed with Image J software (NIH). Histograms show mean ± SEM of four-five
independent experiments. (a.u.: arbitrary units). *p < 0.05 hATT (both) vs. hATN; **p < 0.05 hATT (attached to tumor) vs. hATT 2 cm away from tumor;
#p = 0.055 hATT (2 cm from the tumor) vs. hATN. Magnification: 100X
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Additionally, our results show that in breast cancer
epithelial cells, hATT-CMs increase: 1) membrane glyco-
protein CD44 (which plays a key role in cell adhesion as
well as in cell migration); 2) metalloproteinase
ADAMTS1 (which is capable of proteoglycan cleavage
and ECM degradation); 3) adiponectin type 1 receptor
(one of adiponectin receptors). In order to mechanistically
evaluate the importance of these genes in cell prolifera-
tion, adhesion and migration, we will perform a loss- or
gain-of-function in future experiments.
The identification of factors involved in the interaction
between adipose and breast epithelial tissue could poten-
tially allow us to regulate the expression of one or more
of these factors in order to reverse tumor behavior.
Our results showed an increase of versican expression
in CMs from hATT compared to CMs from hATN. This
could indicate that verisican might be involved in the
regulation of cell proliferation, adhesion and migration.
To confirm, we performed an additional experiment in
which we evaluated cell migration of MCF-7 and IBH-7
incubated with control-, hATN- and hATT-CMs pre-
treated (or not) with Chondroitinase ABC, an en-
zyme that degrades versican’s GAG chains. It has
been reported that versican interacts with CD44, and
this interaction depends on versican’s GAG chains [32,
33]. We found a loss of effect in cell migration
values when hATT-CMs were pretreated with Chon-
droitinase ABC, thus strengthening the view that
versican produced by adipocytes is involved at least
in part in the biological effects seen in Pistone
Creydt et al. [12].
ADAMTS1 gene is down-regulated in breast carcin-
omas with respect to non neoplastic mammary tissue
[20]. Nevertheless it has been recently demonstrated that
ADAMTS1 promotes breast tumor cell migration by
regulating the release of semaphorin 3c from the ECM
[34]. These apparently contradictory results could be
due to the fact that ADAMTS1 presents two distinct
active forms, an 87 kDa and a 65 kDa form, which have
been describe to present different functions [35]. Al-
though we didn’t find a significant difference in the
levels of the 65 kDa form of this metalloproteinase in
the hATT-CMs and hATN-CMs, a tendency to be in-
creased in the hATN-CMs was seen. Since the 65 kDa
form is mainly detached from the ECM and it has been
reported to have anti-angiogenic properties, this could
show a way in which a normal adipose microenviron-
ment prevents angiogenesis in distant locations. None-
theless, more samples need to be assessed to confirm
these results. Furthermore, since an increase in
ADAMTS1 expression not necessarily correlates with an
increase in ADAMTS1 activity, we shall measure the
activity of this peptidase in the different CMs and in the
lysates of cells treated with the CMs.
In the last few years, several groups have demonstrated
the importance of the dialogue that is established in the
invasive front between tumor cells and stromal adipocytes
[6, 7]. Tumor cells would be able to modify adipocyte
phenotype, which in turn would stimulate the tumor’s
aggressive behavior and local invasion [8]. We observed
that the characteristics of the connective tissue were
modified in response to the local invasion of tumor cells.
Specifically, adipocytes associated to the tumor’s invasive
front showed a reduced size compared to those found
farther away (2 cm) and from adipocytes from normal
breasts. In addition, we observed a significantly higher
expression of versican, CD44 and Adipo R1, and signifi-
cantly lower expression of adiponectin and perilipin, in
hATT adipocytes compared to hATN adipocytes. We
believe that the observed overexpression of Adipo R1 in
both hATT tissue explants, and MCF-7 and IBH-7 cells
incubated with hATT-CMs are an up-regulation compen-
satory mechanism as a consequence of the decreased
levels of adiponectin secreted by peritumoral adipocytes.
Serum adiponectin levels have been seen to significantly
decrease in breast-cancer patients, while antiproliferative
effects of adiponectin, as well as cell cycle inhibition and
activation of apoptosis have been verified in most studies
[36]. Our results are in line with these previous experi-
ments, since they show that adiponectin levels are
decreased in hATT tissue explants. In addition, we
observed that perilipin (marker of mature adipocytes) is
decreased and CD44 is increased in hATT versus hATN.
This would mean that the adipocytes of the tumor micro-
environment present a less differentiated state than the
adipocytes of the normal microenvironment. This would
indicate a loss in normal functions of mature adipocytes,
such as energy storage, by others that could be favoring
tumor development. These results begin to clarify early
phenotypic and genotypic changes that undergo adipo-
cytes that are in direct contact or farther away from the
invasive tumor epithelium.
Conclusions
We conclude that versican, a proteoglycan that is
overexpressed in hATT-CMs compared to hATN-
CMs, might be involved in the tumorogenic behavior
observed in both cell lines employed. In addition, we
may conclude that adipocytes from the tumor micro-
environment show a less differentiated state than
adipocytes from normal microenvironment. This
would indicate a loss of normal functions in mature
adipocytes (such as energy storage), in support of
others that might favor tumor growth. The analysis
and characterization of the factors that modify their
expression, both in adipose tissue as well as epithelial
cells, and the study of the involvement of these
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factors in the regulation of tumor progression, might
allow developing new strategies to prevent and/or
treat breast cancer.
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